Heterotopic ossification

Heterotopic Ossification (HO) is a pathological process characterized by the abnormal formation of mature, lamellar bone in non-osseous tissues. This condition often occurs after traumatic injuries or surgeries and can lead to significant complications such as pain, joint contractures, and loss of range of motion.

Etiology

The exact cause of Heterotopic Ossification is not fully understood. However, it is believed to be triggered by an inflammatory response to tissue injury. This can occur following trauma, burns, central nervous system injuries, or orthopedic surgeries. Certain genetic conditions, such as Fibrodysplasia ossificans progressiva, are also associated with HO.

Pathophysiology

In Heterotopic Ossification, there is an aberrant differentiation of mesenchymal stem cells into osteoblastic lineage cells, leading to bone formation in soft tissues. This process is regulated by various growth factors and cytokines, including bone morphogenetic proteins (BMPs), transforming growth factor-beta (TGF-beta), and others.

Clinical Presentation

Patients with HO may present with pain, swelling, warmth, and decreased range of motion in the affected area. The symptoms usually appear several weeks after the inciting event. In severe cases, HO can lead to joint ankylosis and significant functional impairment.

Diagnosis

The diagnosis of HO is typically made based on clinical findings and imaging studies. Radiographs can show the presence of ectopic bone, but they may not be positive until 2-6 weeks after symptom onset. Computed tomography (CT) and magnetic resonance imaging (MRI) can detect HO earlier than radiographs.

Treatment

The treatment of HO includes conservative measures such as physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs). In cases where HO causes significant functional impairment, surgical excision of the ectopic bone may be necessary. However, there is a high risk of recurrence after surgery. Pharmacological prophylaxis with NSAIDs or bisphosphonates is often used to prevent HO after high-risk surgeries.

Prognosis

The prognosis of HO depends on the severity of the condition and the patient's overall health status. With appropriate treatment, many patients can achieve good functional outcomes. However, HO can cause significant morbidity in severe cases.

See Also

• Fibrodysplasia ossificans progressiva
• Bone morphogenetic proteins
• Nonsteroidal anti-inflammatory drugs

   This article is a medical stub. You can help WikiMD by expanding it!